Ronny Gal analyst BERNSTEIN

Currently out of the existing stock ratings of Ronny Gal, 15 are a HOLD (39.47%), 23 are a BUY (60.53%).

Ronny Gal

Work Performance Price Targets & Ratings Chart

Analyst Ronny Gal, currently employed at BERNSTEIN, carries an average stock price target met ratio of 71.31% that have a potential upside of 22.84% achieved within 344 days.

Ronny Gal’s has documented 78 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ABBV, AbbVie at 17-Oct-2024.

Wall Street Analyst Ronny Gal

Analyst best performing recommendations are on JAZZ (JAZZ PHARMACEUTICALS PLC).
The best stock recommendation documented was for JAZZ (JAZZ PHARMACEUTICALS PLC) at 10/14/2019. The price target of $150 was fulfilled within 44 days with a profit of $32.35 (27.5%) receiving and performance score of 6.25.

Average potential price target upside

BIIB Biogen PFE Pfizer REGN Regeneron Pharmaceuticals ABBV AbbVie GILD Gilead Sciences VTRS Viatris JAZZ Jazz Pharmaceuticals PLC TEVA Teva Pharma Industries Ltd ADR AMGN Amgen AGN Allergan plc MNTA Momenta Pharmaceuticals MYL Viatris

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 13-Feb-2025

$222

$22.85 (11.47%)

$224

4 days ago
(08-Jul-2026)

38/66 (57.58%)

$21.64 (10.80%)

321

Buy Since 04-Mar-2022

$242

$42.85 (21.52%)

$227

5 days ago
(07-Jul-2026)

48/83 (57.83%)

$36.3 (17.65%)

148

Buy Since 29-Jun-2026

$256

$56.85 (28.55%)

$255

13 days ago
(29-Jun-2026)

7/37 (18.92%)

$39.37 (18.17%)

256

Buy Since 28-Sep-2022

$221

$4.97 (2.30%)

$177

27 days ago
(15-Jun-2026)

24/40 (60%)

$22.36 (11.26%)

155

Buy Since 15-May-2026

$225

$8.97 (4.15%)

$214

1 months 27 days ago
(15-May-2026)

4/8 (50%)

$32.05 (16.61%)

54

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Ronny Gal?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?